8 hours ago
1
Pharrel Wiliams
H.C. Wainwright upgraded Savara (NASDAQ:SVRA) to Buy from Neutral and raised its price target to $5 from $2 per share on Friday, citing a potential resubmission of the company’s marketing application for its lead asset, Molbreevi, with the FDA.
The
English (US) ·